Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis

被引：86
作者：
Fafi-Kremer, S
Morand, P
Brion, JP
Pavese, P
Baccard, M
Germi, R
Genoulaz, O
Nicod, S
Jolivet, M
Ruigrok, RWH
Stahl, JP
Seigneurin, JM
机构：
[1] Univ Grenoble 1, EA 2939, Lab Virol Mol & Struct, Grenoble, France
[2] Ctr Hosp Univ, Med Virol Lab, Grenoble, France
[3] Ctr Hosp Univ, Serv Malad Infect, Grenoble, France
[4] bioMerieux, Lyon, France
来源：
JOURNAL OF INFECTIOUS DISEASES | 2005年 / 191卷 / 06期
关键词：
D O I：
10.1086/428097
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Epstein-Barr virus (EBV) DNA loads in peripheral blood mononuclear cells (PBMCs), plasma, and saliva, as well as infectivity of the virus in saliva, were evaluated in 20 patients for 6 months after the onset of infectious mononucleosis (IM). All patients displayed sustained high EBV DNA loads in the saliva, associated with a persistent infectivity of saliva at day 180. EBV DNA load in PBMCs decreased significantly from day 0 to day 180 ( in spite of a viral rebound between day 30 and day 90 in 90% of the patients), and EBV DNA rapidly disappeared from plasma. These data show that patients with IM remain highly infectious during convalescence.
引用
收藏
页码：985 / 989
页数：5
相关论文
共 16 条
[11]   Epstein-Barr virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies [J].
Ryan, JL ;
Fan, HX ;
Swinnen, LJ ;
Schichman, SA ;
Raab-Traub, N ;
Covington, M ;
Elmore, S ;
Gulley, ML .
DIAGNOSTIC MOLECULAR PATHOLOGY, 2004, 13 (02) :61-68
[12]   Biology of Epstein-Barr virus during infectious mononucleosis [J].
Sitki-Green, DL ;
Edwards, RH ;
Covington, MM ;
Raab-Traub, N .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (03) :483-492
[13]   Analysis of immune activation and clinical events in acute infectious mononucleosis [J].
Williams, H ;
Macsween, K ;
McAulay, K ;
Higgins, C ;
Harrison, N ;
Swerdlow, A ;
Britton, K ;
Crawford, D .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) :63-71
[14]   Primary immune responses by cord blood CD4+ T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro [J].
Wilson, AD ;
Morgan, AJ .
JOURNAL OF VIROLOGY, 2002, 76 (10) :5071-5081
[15]   DETECTION AND QUANTIFICATION OF VIRUS-DNA IN PLASMA OF PATIENTS WITH EPSTEIN-BARR VIRUS-ASSOCIATED DISEASES [J].
YAMAMOTO, M ;
KIMURA, H ;
HIRONAKA, T ;
HIRAI, K ;
HASEGAWA, S ;
KUZUSHIMA, K ;
SHIBATA, M ;
MORISHIMA, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (07) :1765-1768
[16]   EPSTEIN-BARR VIRUS-INFECTED B-CELLS PERSIST IN THE CIRCULATION OF ACYCLOVIR-TREATED VIRUS CARRIERS [J].
YAO, QY ;
OGAN, P ;
ROWE, M ;
WOOD, M ;
RICKINSON, AB .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (01) :67-71
12